Table 1. Comparison of general characteristics of patients with peripheral artery disease and controlled or uncontrolled hypertension.

Variables		Controlled hypertension	Uncontrolled hypertension	p value
Clinical and demographic variables
	Male sex (%)	(53.6)	(46.4)	0.130
	Age (years)	65±10	69±8	0.001
	Ankle-brachial index	0.60±0.19	0.57±0.16	0.245
	Body mass index (kg/m²)	28.0±4.9	27.4±4.7	0.342
	Claudication distance (m)	133±85	125±68	0.465
	Six-minute walk test (m)	326±91	318±85	0.531
	Systolic blood pressure (mmHg)	121±12	158±15	<0.001
	Diastolic blood pressure (mmHg)	69±10	78±10	<0.001
Comorbidities
	Current smoker (%)	(42.9)	(57.1)	0.334
	Diabetes (%)	(48.4)	(51.7)	0.633
	Dyslipidemia (%)	(53.2)	(46.8)	0.056
	Obesity (%)	(52.6)	(47.4)	0.642
	Coronary artery disease (%)	(55.6)	(44.4)	0.241
	Stroke (%)	(56.1)	(43.9)	0.806
Medications
	Antiplatelet	(51.2)	(48.8)	0.949
	ACE inhibitor (%)	(64.9)	(35.1)	0.018
	Angiotensin-receptor antagonist (%)	(48.4)	(51.6)	0.579
	Calcium channel blocker (%)	(47.5)	(52.5)	0.481
	Diuretic (%)	(45.5)	(54.5)	0.152
	Beta-blocker (%)	(51.6)	(48.4)	0.924
	Statin (%)	(53.2)	(46.8)	0.137
	Hypoglycemic (%)	(47.7)	(52.3)	0.371
	Peripheral vasodilator (%)	(58.5)	(41.5)	0.219
	ACE inhibitor + diuretic + calcium channel blocker (%)	(53.8)	(46.2)	0.904

Values expressed as median±interquartile range and frequency.

ACE: angiotensin conversion enzyme.